Vivos Therapeutics, Inc. Forms Clinical Advisory Board to Drive Further Growth of Next-Generation Obstructive Sleep Apnea Treatment Efforts
January 29, 2021 at 08:00 am EST
Share
Vivos Therapeutics, Inc. announced that the company has established Clinical Advisory Board to further drive adoption and growth of its next-generation treatments for OSA, of which 1 billion people suffer from globally. Members of Vivos’ Clinical Advisory Board currently include: Clete A. Kushida, MD, PhD – Neurologist, sleep specialist, Stanford Sleep Medicine Center’s Division Chief and Medical Director, World Sleep Society’s founding President; Edward Zuckerberg, DDS – Nationally recognized key opinion leader in the advanced dentistry field; Michael Gelb, DDS, MS – American Board of Orofacial Pain Diplomate, NYU College of Dentistry Clinical Professor, American Academy of Physiological Medicine and Dentistry Co-Founder; Manisha Witmans, MD, FAASM – Board-certified sleep specialist and pediatric pulmonologist, Associate Clinical Professor at the University of Alberta; Tammarie Heit, DDS, MICCMO, RN – Completed mastership program at the International College of Craniomandibular Orthopedics, established private practice focused on craniofacial sleep medicine and dentistry; and Jon Caulfield, DDS – American Sleep and Breathing Academy Diplomate; established private practice specializing in airway, sleep and TMJ disorders.
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as obstructive sleep apnea (OSA) and snoring in adults. The Company calls its solution The Vivos Method. The Vivos Method represents the first clinically effective nonsurgical, noninvasive and nonpharmaceutical solution for treating mild to severe OSA. The Vivos Method includes treatment regimens that employ the proprietary Complete Airway Repositioning and/or Expansion (CARE) appliance therapy and other modalities that alter the size, shape and position of the soft tissues that comprise a patient's upper airway and/or palate. The Vivos Method comprises various products and services, including Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, and Vivos Airway Intelligence Service.
VIVOS THERAPEUTICS, INC. 
